Kennedy Health Officials Explore U.S. Ban on Certain SSRI Antidepressants
Robert F. Kennedy Jr. announced initiatives at a May 11, 2026 Mental Health and Overmedicalization Summit to reduce use of SSRI antidepressants including Zoloft, Prozac and Lexapro. One in six U.S. adults currently take SSRI medications. Any restrictions would require the U.S. Food and Drug Administration to demonstrate strong scientific evidence that risks outweigh benefits, as the FDA has authority over SSRI use.
SSRI ban discussions
▪U.S. health department officials explored whether they could ban certain drugs in the selective serotonin reuptake inhibitor (SSRI) class of antidepressants during the week before May 8, 2026.
▪Andrew Nixon, spokesman for Robert F. Kennedy Jr.'s Health and Human Services Department, stated the department has not had any discussions about banning SSRIs.
Kennedy's antidepressant reduction initiatives
▪Robert F. Kennedy Jr. has agreed to shift focus away from vaccine policy amid White House tensions and ahead of November 2026 midterm elections.
▪Robert F. Kennedy Jr.'s initiatives include reimbursement guidelines for physicians who help patients come off of SSRI medications.
▪Robert F. Kennedy Jr.'s initiatives include an investment in training for healthcare providers regarding SSRIs.
▪Robert F. Kennedy Jr. announced initiatives on May 11, 2026 intended to reduce SSRI use.
▪Robert F. Kennedy Jr. announced the initiatives at a Mental Health and Overmedicalization Summit on May 11, 2026.
▪Robert F. Kennedy Jr.'s initiatives include plans to share data on SSRI prescribing trends.
Kennedy's claims about SSRIs
▪About one in six U.S. adults reported currently taking SSRI medications according to a 2026 study in the medical journal BMJ Mental Health.
▪Robert F. Kennedy Jr. said in November 2025 that the Centers for Disease Control and Prevention was studying whether SSRI therapies contribute to mass violence.
▪Robert F. Kennedy Jr. has argued that SSRI antidepressants have been overprescribed, especially to children.
▪Robert F. Kennedy Jr. has previously said that withdrawal symptoms from SSRIs are worse than those from heroin.
▪Robert F. Kennedy Jr. has, without evidence, linked SSRIs to violence, including mass shootings.
Medical community response
▪The American Psychiatric Association considers SSRIs a first option, evidence-based treatment for depression.
▪The American Psychiatric Association pushed back on framing the mental health crisis as primarily one of overprescribing.
▪The American Psychiatric Association supports better research to guide SSRI treatment decisions.
FDA regulatory authority
▪The FDA lacks authority to unilaterally ban already-approved medications without new safety evidence or proof of false statements in the original application.
▪Any new restrictions on SSRIs would require strong scientific evidence of a risk to patients that outweighs their benefits.
▪Drugmakers can refuse FDA withdrawal requests, as Amgen did when the FDA sought to pull Amgen's autoimmune drug Tavneos.
▪The U.S. Food and Drug Administration has authority over SSRI use.
Perspective of American Psychiatric Association
▪The American Psychiatric Association considers SSRIs a first option, evidence-based treatment for depression.
▪The American Psychiatric Association pushed back on framing the mental health crisis as primarily one of overprescribing.
Story comments
Loading comments…